Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
B 116.83 0.94% 1.09
LNTH closed down 4.83 percent on Thursday, July 18, 2024, on 1.49 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 1
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.94%
Outside Day Range Expansion 0.94%
Wide Bands Range Expansion 0.94%
Overbought Stochastic Strength 0.94%
180 Bullish Setup Bullish Swing Setup -3.93%
Calm After Storm Range Contraction -3.93%
Upper Bollinger Band Walk Strength -3.93%
Multiple of Ten Bullish Other -3.93%
Inside Day Range Contraction -3.93%
Wide Bands Range Expansion -3.93%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 3 hours ago
Possible Inside Day about 3 hours ago
Up 2% about 7 hours ago
Up 1% about 7 hours ago
Down 5% 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Lantheus Holdings, Inc. Description

Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Disease Chemical Elements Prostate Cancer Heart Failure Medical Imaging Stroke Medical Physics Artery Perfusion Artery Disease Imaging Agent Peripheral Vascular Disease Radiopharmaceuticals Congestive Heart Failure Coronary Artery Disease Gallium Neuron Cardiovascular And Other Diseases Medicinal Radiochemistry Myocardial Perfusion Imaging

Is LNTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 126.8899
52 Week Low 50.2
Average Volume 1,053,987
200-Day Moving Average 68.93
50-Day Moving Average 85.25
20-Day Moving Average 93.35
10-Day Moving Average 106.75
Average True Range 5.76
RSI (14) 70.15
ADX 42.72
+DI 43.55
-DI 14.49
Chandelier Exit (Long, 3 ATRs) 109.62
Chandelier Exit (Short, 3 ATRs) 93.37
Upper Bollinger Bands 131.48
Lower Bollinger Band 55.22
Percent B (%b) 0.79
BandWidth 81.69
MACD Line 10.93
MACD Signal Line 7.37
MACD Histogram 3.5653
Fundamentals Value
Market Cap 7.93 Billion
Num Shares 68.5 Million
EPS 1.50
Price-to-Earnings (P/E) Ratio 77.16
Price-to-Sales 3.21
Price-to-Book 5.51
PEG Ratio 0.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 128.61
Resistance 3 (R3) 129.54 126.19 126.47
Resistance 2 (R2) 126.19 122.91 125.72 125.75
Resistance 1 (R1) 120.96 120.88 119.29 120.03 125.03
Pivot Point 117.61 117.61 116.77 117.14 117.61
Support 1 (S1) 112.38 114.33 110.71 111.45 106.45
Support 2 (S2) 109.03 112.30 108.56 105.73
Support 3 (S3) 103.80 109.03 105.02
Support 4 (S4) 102.87